
|Articles|April 25, 2023
Considering Comparability in Cell and Gene Therapy with Michael Blackton (INTERPHEX 2023)
Michael Blackton, senior vice-president of technical operations at Elektrofi, speaks about comparability in cell and gene therapy.
Advertisement
Michael Blackton, senior vice-president of technical operations at Elektrofi, speaks about comparability in cell and gene therapy. He also touches on autologous and allogeneic cell therapy, as well as looking towards the future of cell and gene therapy.
For more INTERPHEX 2023 video content, check
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
2
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
3
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
4
How Biopharma Navigates the 2026 Economic Shift
5




